Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 58.6B | 58.9B | 54.2B | 46.0B |
Cost of revenue | 20.2B | 20.0B | 18.0B | 14.8B |
Gross profit | 38.4B | 38.9B | 36.2B | 31.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 6.9B | 6.4B | 5.8B | 4.9B |
Other operating expenses | 11.0B | 8.8B | 8.8B | 7.5B |
Operating income | 6.4B | 9.8B | 8.0B | 5.5B |
Non operating interest income | ||||
Income | 17M | 17M | 26M | 5M |
Expense | 710M | 748M | 731M | 753M |
Other income expense | — | — | — | — |
Pretax income | 5.3B | 9.2B | 7.5B | 5.0B |
Tax provision | -3.2B | 1.6B | 1.4B | 1.2B |
Net income | 8.5B | 7.6B | 6.1B | 3.8B |
Basic EPS | — | — | — | 38.0 |
Diluted EPS | — | — | — | 38.0 |
Basic average shares | — | — | — | 93.1M |
Diluted average shares | — | — | — | 93.1M |
EBITDA | 13.5B | 17.2B | 15.4B | 12.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -3.4B | -1.7B | -1.4B | -299M |
Preferred stock dividends | 0 | 0 | 0 | 0 |